Atrial Fibrillation Clinical Trials

Find Atrial Fibrillation Clinical Trials Near You

Comparison of Maximum Energy Shocks From Two Defibrillator Vendors MAX - SHOCK- A Randomized Controlled Clinical Trial

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Can Electrical Cardioversion (ECV) for AF be improved. It is the preferred method to restore sinus rhythm in patients with AF in whom a rhythm-control strategy is pursued. Hypothesis: ECV success rates will be greater with a biphasic defibrillator with maximum energy of 360J (® Physio-Control) compared to a biphasic defibrillator with maximum energy of 200J (® Zoll)

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients age \> 18 years.

• Persistent atrial fibrillation.

• Scheduled for elective cardioversion at UOHI

• Patient is within the circle of care of UOHI Electrophysiology staff

Locations
Other Locations
Canada
University of Ottawa Heart Institute
RECRUITING
Ottawa
Contact Information
Primary
Tammy Knight
tknight@ottawaheart.ca
613-696-7000
Backup
David Birnie
dbirnie@ottawaheart.ca
613-696-7000
Time Frame
Start Date: 2025-03-31
Estimated Completion Date: 2027-09-01
Participants
Target number of participants: 376
Treatments
Active_comparator: 200J
biphasic defibrillator with maximum energy of 200J (® Zoll)
Active_comparator: 360J
biphasic defibrillator with maximum energy of 360J (® Physio-Control)
Related Therapeutic Areas
Sponsors
Leads: Ottawa Heart Institute Research Corporation

This content was sourced from clinicaltrials.gov